Patents by Inventor Michael Baratta
Michael Baratta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230263972Abstract: Various exemplary drug delivery devices with on-board drug destruction, drug products utilizing the same, and methods of using drug delivery devices with on-board drug destruction are provided. In general, a nasal drug delivery device configured to dispense a drug therefrom into a nose includes a destruction mechanism configured to destroy drug contained in the drug delivery device. The destruction mechanism can be configured to destroy the drug before a first actuation of the drug delivery device to deliver the drug therefrom such that the destruction mechanism destroys substantially all of the drug contained in the drug delivery device. Alternatively or in addition, the destruction mechanism can be configured to destroy the drug after a first actuation of the drug delivery device to deliver the drug therefrom such that the destruction mechanism destroys substantially all of the drug remaining in the drug delivery device.Type: ApplicationFiled: September 1, 2021Publication date: August 24, 2023Inventors: Emma Louise HUBERT, Monica A. KAPIL, MingQi ZHAO, Steven M. VESOLE, Ian SCRIMGEOUR, David RAMOS, Jaskaran SINGH, Jingli WANG, David KALIKHMAN, Shagun POPLI, Peter KRULEVITCH, Hong YAN, Michael A. BARATTA, Whitney PHILLIPS, Francesco N. ALBERTINI, Michael CANNAMELA
-
Publication number: 20220409127Abstract: In general, methods, systems, and devices for remote aggregation of data for drug administration devices are provided. In one exemplary embodiment, data indicative of information sensed with a sensor of a drug administration device can be wirelessly transmitted from a drug administration device to a server. The server can use the data to correlate the patients use of the drug with the patients clinical outcome, perform a cost analysis of the patients treatment, determine whether the drug was delivered to the patient in compliance with the patients treatment plan, identify a malfunction in the administration of the drug, determine that additional data is needed from the drug administration device and trigger a request for the additional data to be wirelessly transmitted from the server to the drug administration device, and/or predictively model the patients clinical outcome.Type: ApplicationFiled: September 24, 2020Publication date: December 29, 2022Inventors: Francesco N. ALBERTINI, Michael A. BARATTA, Jason L. HARRIS, Emma Louise HUBERT, Michael HUTCHINSON, David KALIKHMAN, Monica A. KAPIL, Peter KRULEVITCH, Shagun POPLI, Frederick E. Shelton, IV, Jaskaran SINGH, Jingli WANG
-
Publication number: 20220336074Abstract: In general, interconnection of drug administration systems is provided. In an exemplary embodiment, a drug administration device and a remotely located server can establish a unique key for wireless communication between the device and the server. The drug administration device can be configured to sense information relating to at least one of the device and a drug and can be configured to anonymize data indicative of the sensed information using the key stored in memory of the device. The drug administration device can also be configured to use the key in decrypting data received from the server.Type: ApplicationFiled: September 24, 2020Publication date: October 20, 2022Inventors: Gregory J. BAKOS, Michael A. BARATTA, Yueheng DOU, Jason L. HARRIS, Emma Louise HUBERT, Monica A. KAPIL, Peter KRULEVITCH, Wouter Jacques Noel LEQUIEU, Dolores PEREZ, Whitney PHILLIPS, Frederick E. SHELTON, Hong YAN
-
Patent number: 11381061Abstract: A system for servicing cable includes a field-end assembly and a live-end assembly, each mounted on a support structure having at least one drive mechanism operable to cause relative linear movement between the field-end assembly and the live-end assembly. A drilling-and-shorting assembly can create a short circuit in a field-end of the cable, and a continuity tester can test the integrity of the short-circuit. The field end of the cable can then be ejected from the system, and an end-cap-cradle assembly can position an end cap on a live end of an electrical cable and test its installation.Type: GrantFiled: December 16, 2019Date of Patent: July 5, 2022Assignees: ULC Technologies, LLC, Consolidated Edison Company of New York, Inc.Inventors: Alex Symington, Dennis John Semet, Caner Oktayer, Aalap Rajendra Shah, Than Lin Htaik, Patrick McHugh, Maggie Chow, George Murray, Luis Jerez, Thomas Campbell, Michael Baratta
-
Publication number: 20200194978Abstract: A system for servicing cable includes a field-end assembly and a live-end assembly, each mounted on a support structure having at least one drive mechanism operable to cause relative linear movement between the field-end assembly and the live-end assembly. A drilling-and-shorting assembly can create a short circuit in a field-end of the cable, and a continuity tester can test the integrity of the short-circuit. The field end of the cable can then be ejected from the system, and an end-cap-cradle assembly can position an end cap on a live end of an electrical cable and test its installation.Type: ApplicationFiled: December 16, 2019Publication date: June 18, 2020Inventors: Alex SYMINGTON, Dennis John SEMET, Caner OKTAYER, Aalap Rajendra SHAH, Than Lin HTAIK, Patrick McHUGH, Maggie CHOW, George MURRAY, Luis JEREZ, Thomas CAMPBELL, Michael BARATTA
-
Patent number: 8910638Abstract: In exemplary implementations of this invention, high-throughput screening of a mammalian brain is performed to locate neural circuit targets of interest. A variety of search patterns may be used for this neural screening, including (a) iterative subdivision, (b) serial search, and (c) combinatorial. To perform this neural screening, an array of optical fibers (or an array of waveguides) is inserted into the brain. Alternately, the array is positioned adjacent to the brain. Each fiber or waveguide in the array is coupled to a light source (LED or laser). The brain has been previously sensitized to light, using genetically encoded optical neural control reagents, which are delivered either using viruses or via transgenic means. In the screening, the array is used to optically perturb the brain. For example, the neurons of the brain may be activated by one color of light, and/or silenced by another color of light.Type: GrantFiled: October 24, 2011Date of Patent: December 16, 2014Assignee: Massachusetts Institute of TechnologyInventors: Edward Boyden, Jacob Bernstein, Christian Wentz, Giovanni Talei Franzesi, Michael Baratta, Brian Allen, Anthony Zorzos, Jorg Scholvin, Clifton Fonstad
-
Publication number: 20140164341Abstract: A method and apparatus for populating a contact in an address book on a mobile computing device. In some embodiments, the method includes receiving data associated with a first entity, processing the data received to extract contact information associated with the first entity, populating a user contact entry based on the extracted contact information, and storing the populated user contact in the address book.Type: ApplicationFiled: December 11, 2012Publication date: June 12, 2014Applicant: VONAGE NETWORK LLCInventors: MICHAEL BARATTA, TZAHI EFRATI
-
Publication number: 20120089205Abstract: In exemplary implementations of this invention, high-throughput screening of a mammalian brain is performed to locate neural circuit targets of interest. A variety of search patterns may be used for this neural screening, including (a) iterative subdivision, (b) serial search, and (c) combinatorial. To perform this neural screening, an array of optical fibers (or an array of waveguides) is inserted into the brain. Alternately, the array is positioned adjacent to the brain. Each fiber or waveguide in the array is coupled to a light source (LED or laser). The brain has been previously sensitized to light, using genetically encoded optical neural control reagents, which are delivered either using viruses or via transgenic means. In the screening, the array is used to optically perturb the brain. For example, the neurons of the brain may be activated by one color of light, and/or silenced by another color of light.Type: ApplicationFiled: October 24, 2011Publication date: April 12, 2012Applicant: MASSACHUSETTS INSTITUTE OF TECHNOLOGYInventors: Edward Boyden, Jacob Bernstein, Christian Wentz, Giovanni Talei Franzesi, Michael Baratta, Brian Allen, Anthony Zorzos, Jorg Scholvin, Clifton Fonstad